Post Profile






Watson Said to Near $6.6 Billion Deal for Actavis

Watson Pharmaceuticals is expected to bid as much as €5 billion ($6.6 billion) for the Swiss drug maker Actavis Group, in a deal that would create one of the world's largest generic drug manufacturers.
read more

share

Related Posts


Generic Drug Makers in $7.5 Billion Deal

Business & Finance : DealBook (7 years ago)

Teva Pharmaceuticals Industries, the world’s largest maker of generic drugs, confirmed Friday it would buy Barr Pharmaceuticals of New Jersey for about $7.5 billion in cash and stock. Early reports of such a deal sent shares of Barr...

Watson’s Bottom Line to Get Lift From Actavis

Business & Finance : Deal Journal - WSJ.com (2 years ago)

Generic drug maker Actavis is growing faster than the European sector, according to its chief executive and is set to contribute at least €2 billion ($2.6 billion) to this year's sales of U.S. based Watson Pharmaceuticals, which bou...

Watson in Talks to Buy Swiss Drugmaker Actavis - Businessweek

Medical / Pharmaceutical : PharmaGossip (3 years ago)

Watson Pharmaceuticals Inc. (WPI) is in talks to buy Actavis Group hf, a Swiss maker of generic drugs, a person with knowledge of the matter said. Watson made an unsolicited approach to Actavis, said the person, who declined to be i...

Analysts Get Hooked On Watson After Actavis Deal

Business & Finance / Investing : CNBC Stock Blog (3 years ago)

Although Watson Pharmaceuticals’ acquisition of Swiss generic drug maker Actavis was expected for over a month, a strong reaction to Wednesday’s deal shows that analysts are hooked on the drugmaker.

Watson Said to Bid $5.9 Billion for Actavis

Business & Finance : DealBook (3 years ago)

Watson Pharmaceuticals is expected to offer 4.5 billion euros ($5.9 billion) for Swiss drug maker Actavis Group on Wednesday, in a deal that would create one of the world's largest generic drug manufacturers.

Comments



Copyright © 2015 Regator, LLC